TY - JOUR T1 - Longitudinal symptom dynamics of COVID-19 infection in primary care JF - medRxiv DO - 10.1101/2020.07.13.20151795 SP - 2020.07.13.20151795 AU - Barak Mizrahi AU - Smadar Shilo AU - Hagai Rossman AU - Nir Kalkstein AU - Karni Marcus AU - Yael Barer AU - Ayya Keshet AU - Na’ama Shamir-Stein AU - Varda Shalev AU - Anat Ekka Zohar AU - Gabriel Chodick AU - Eran Segal Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/14/2020.07.13.20151795.abstract N2 - Importance Data regarding the clinical characteristics of COVID-19 infection is rapidly accumulating. However, most studies thus far are based on hospitalized patients and lack longitudinal follow up. As the majority of COVID-19 cases are not hospitalized, prospective studies of symptoms in the population presenting to primary care are needed.Objective To assess the longitudinal dynamic of clinical symptoms in non-hospitalized individuals prior to and throughout the diagnosis of SARS-CoV-2 infection.Design, Setting, and Participants From 1/3/2020 to 07/06/2020, information on symptoms from either surveys or primary care visits was available for 206,377 individuals, including 2,471 who tested positive for COVID-19. Data were extracted from electronic health records (EHR) of the second largest Health Maintenance Organization in Israel, consisting of both results of PCR tests and symptoms recorded by primary care physicians, and linked longitudinal self reported symptoms.Exposures Diagnosis of COVID-19 disease was made by PCR testing for SARS-CoV-2 from nasopharyngeal swabs.Main Outcomes and Measures Longitudinal prevalence of clinical symptomsResults In adults, the most prevalent symptoms recorded in EHR were cough (11.6%), fever (10.3%), and myalgia (7.7%) and the most prevalent self-reported symptoms were cough (21%), fatigue (19%) and rhinorrhea and/or nasal congestion (17%). In children, the most prevalent symptoms recorded in the EHR were fever (7%), cough (5.5%) and abdominal pain (2.4%). Emotional disturbances were documented in 15.9% of the positive adults and 4.2% of the children. Loss of taste and smell, either self-reported or documented by a physician, 3 weeks prior to testing, were the most discriminative symptoms in adults (OR =11.18 and OR=5.47 respectively). Additional symptoms included self reported confusion (OR =4.02), and fatigue (OR = 1.73) and a documentation of syncope, rhinorrhea (OR = 2.09 for both) and fever (OR= 1.62) by a physician. Mean time to recovery was 23.5 ± 9.9 days. Children had a significantly shorter disease duration (21.7 ± 8.8 days, p-value=0.01). Several symptoms, including fatigue, myalgia, runny nose and shortness of breath were reported weeks after recovery.Conclusions and Relevance As the COVID-19 pandemic progresses rapidly worldwide, obtaining accurate information on symptoms and their progression is of essence. Our study shed light on the full clinical spectrum of symptoms experienced by infected individuals in primary care, and may alert physicians for the possibility of COVID-19 infection.Question What is the longitudinal dynamic of symptoms among individuals with coronavirus disease 2019 (COVID-19) in primary care?Findings Temporal dynamics of symptoms revealed different patterns, with some symptoms lasting weeks after recovery. children have a significantly shorter disease duration and have different prevalence of reported symptoms. Loss of taste and smell prior to diagnosis, were the most discriminative symptoms for COVID-19 infection in adultsMeaning Our study reveals the longitudinal dynamics of symptoms in COVID-19 infection and their expected duration, as well as highlights symptoms that may alert physicians for the possibility of COVID-19 infection and direct the need for isolation and COVID-9 testing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received for this articleAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by Maccabi Health Services' institutional review board (0024-20-MHS)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study originate from Maccabi Health Services. Restrictions apply to the availability of these data and they are therefore not publicly available. Due to restrictions, these data can be accessed only by request to the authors and/or Maccabi Health Services. ER -